Furthermore, we have for the first time shown that VEGFR2 blockade mobilized PCG1α from the cytoplasm to the nucleus of both breast cancer cell lines, as evidenced by confocal imaging and nuclear fraction blotting of PCG1α. The gene discussed is KDR; the disease is breast carcinoma.